American Medical Association President Gerald Harmon, MD, joined us for an exclusive chat about some of the hottest topics discussed at the 2022 AMA House of Delegates meeting.

Meet the Respondents

When it comes to CVIS strategy across the survey base, C-suite leaders and cardiovascular department heads share the responsibility equally often. But in academic medical centers and multi-hospital systems, the division of power is different.

When we dig to unearth cardiovascular care’s top trends, challenges and goals, the findings bring the present into sharp relief: Today’s CV
leaders are focused on growth and committed to improving both quality of care and operational performance. They also have their eyes on
retaining talented staff and reducing clinician burnout.

The CV service line has big goals and is mapping out a route to reach them. Leaders are quite focused but know there are roadblocks and traffic jams in their way.

Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.

As an early career electrophysiologist, Richard I. Fogel, MD, learned to raise his hand when projects needed a captain. Now he’s CEO of the St. Vincent Medical Group in Indianapolis and president of the Heart Rhythm Society (HRS). His formula? Listen, ask good questions, surround yourself with talented people and let them do their jobs, he explains in a Q&A with Cardiovascular Business.